Cytori Announces Corporate Restructuring & Cost Reduction Plan – Nasdaq

SAN DIEGO, Sept. 01, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the “Company”) today announced a substantial corporate restructuring intended to significantly reduce expenses while maintaining its ability to execute on its BARDA-sponsored cell therapy program, Japanese business and oncology program. The Cytori Habeo program for scleroderma is expected to move…

Anchorage Capital Partners buys mini-Spotless – The Australian Financial Review

There”s certainly no shortage of investors looking to clean up from cleaning up Just days after Downer’s $1.2 billion offer for Spotless came to an end – with Downer lifting its stake to just below the compulsory acquisition threshold – Phil Cave and Callen O’Brien’s Anchorage Capital Partners has signed a deal to acquire TJS Services. Founded by…

Evolva Announces Major Restructuring for Next Phase of Its Development – Business Wire (press release)

REINACH, Switzerland–(BUSINESS WIRE)–Evolva (SIX: EVE), which develops and commercializes next-generation specialty ingredients for health, wellness and nutrition markets, details the next phase of its corporate evolution. Evolva announced in its half year results further details of its future intended strategic direction to aggressively grow product revenues and accelerate the path to a cash flow break-even…